The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...
FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
The agency issued a request for more information that will shape new regulation on ingredient transparency.
MedPage Today on MSN
FDA says to drop suicide warning from GLP-1 drug labels
Request based on a comprehensive review of data ...
GlobalData on MSN
Drugmakers welcome FDA’s GLP-1RA suicide warning removal request
The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.
Meanwhile, the FDA has asked manufacturers of flu vaccines to update their labels to include warnings about the risk of ...
The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...
WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results